Harrigan P - Search Results

Year	Number of Results
1971	1
1972	1
1973	3
1974	3
1975	1
1980	1
1981	1
1982	1
1986	1
1987	1
1988	3
1989	4
1990	5
1991	3
1992	7
1993	2
1995	9
1996	5
1997	2
1998	9
1999	11
2000	4
2001	7
2002	8
2003	13
2004	11
2005	13
2006	18
2007	17
2008	17
2009	15
2010	21
2011	18
2012	21
2013	27
2014	35
2015	32
2016	28
2017	28
2018	21
2019	8
2020	10
2021	9
2022	7
2023	5
2024	1

1

Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.

Wong RW, Balachandran A, Cheung PK, Cheng R, Pan Q, Stoilov P, Harrigan PR, Blencowe BJ, Branch DR, Cochrane A. Wong RW, et al. Among authors: harrigan pr. PLoS Pathog. 2024 Apr 9;20(4):e1012155. doi: 10.1371/journal.ppat.1012155. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38593115 Free PMC article.

2

Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries.

Parkin N, Harrigan PR, Inzaule S, Bertagnolio S. Parkin N, et al. Among authors: harrigan pr. PLOS Glob Public Health. 2023 Oct 18;3(10):e0001948. doi: 10.1371/journal.pgph.0001948. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37851634 Free PMC article. Review.

3

The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.

Skrifvars MB, Luethi N, Bailey M, French C, Nichol A, Trapani T, McArthur C, Arabi YM, Bendel S, Cooper DJ, Bellomo R; EPO-TBI Investigators, the ANZICS Clinical Trials Group. Skrifvars MB, et al. Intensive Care Med. 2023 Jul;49(7):831-839. doi: 10.1007/s00134-023-07141-5. Epub 2023 Jul 5. Intensive Care Med. 2023. PMID: 37405413 Free PMC article.

4

On-demand, hospital-based, severe acute respiratory coronavirus virus 2 (SARS-CoV-2) genomic epidemiology to support nosocomial outbreak investigations: A prospective molecular epidemiology study.

Benoit P, Jolicoeur G, Point F, Soucy C, Normand K, Morency-Potvin P, Gagnon S, Kaufmann DE, Tremblay C, Coutlée F, Harrigan PR, Hardy I, Smith M, Savard P, Grandjean Lapierre S. Benoit P, et al. Among authors: harrigan pr. Antimicrob Steward Healthc Epidemiol. 2023 Mar 8;3(1):e45. doi: 10.1017/ash.2023.119. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 36960087 Free PMC article.

5

Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data.

Delaney KE, Ngobeni T, Woods CK, Gordijn C, Claassen M, Parikh U, Harrigan PR, van Zyl GU. Delaney KE, et al. Among authors: harrigan pr. Trop Med Int Health. 2023 Mar;28(3):186-193. doi: 10.1111/tmi.13851. Epub 2023 Jan 13. Trop Med Int Health. 2023. PMID: 36599816 Free PMC article.

6

Single-cell analysis of habituation in Stentor coeruleus.

Rajan D, Makushok T, Kalish A, Acuna L, Bonville A, Correa Almanza K, Garibay B, Tang E, Voss M, Lin A, Barlow K, Harrigan P, Slabodnick MM, Marshall WF. Rajan D, et al. Among authors: harrigan p. Curr Biol. 2023 Jan 23;33(2):241-251.e4. doi: 10.1016/j.cub.2022.11.010. Epub 2022 Nov 25. Curr Biol. 2023. PMID: 36435177 Free PMC article.

7

Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir.

Rhee SY, Parkin N, Harrigan PR, Holmes S, Shafer RW. Rhee SY, et al. Among authors: harrigan pr. Antiviral Res. 2022 Dec;208:105427. doi: 10.1016/j.antiviral.2022.105427. Epub 2022 Sep 30. Antiviral Res. 2022. PMID: 36191692 Free PMC article.

8

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.

Howe AYM, Rodrigo C, Cunningham EB, Douglas MW, Dietz J, Grebely J, Popping S, Sfalcin JA, Parczewski M, Sarrazin C, de Salazar A, Fuentes A, Sayan M, Quer J, Kjellin M, Kileng H, Mor O, Lennerstrand J, Fourati S, Di Maio VC, Chulanov V, Pawlotsky JM, Harrigan PR, Ceccherini-Silberstein F, Garcia F; SHARED Collaborators. Howe AYM, et al. Among authors: harrigan pr. JHEP Rep. 2022 Feb 24;4(5):100462. doi: 10.1016/j.jhepr.2022.100462. eCollection 2022 May. JHEP Rep. 2022. PMID: 35434589 Free PMC article.

9

Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment-limited individuals living with HIV.

Orkin C, Cahn P, Castagna A, Emu B, Harrigan PR, Kuritzkes DR, Nelson M, Schapiro J. Orkin C, et al. Among authors: harrigan pr. HIV Med. 2022 Oct;23(9):936-946. doi: 10.1111/hiv.13288. Epub 2022 Mar 16. HIV Med. 2022. PMID: 35293094 Free PMC article. Review.

10

How have media campaigns been used to promote and discourage healthy and unhealthy beverages in the United States? A systematic scoping review to inform future research to reduce sugary beverage health risks.

Kraak VI, Consavage Stanley K, Harrigan PB, Zhou M. Kraak VI, et al. Among authors: harrigan pb. Obes Rev. 2022 May;23(5):e13425. doi: 10.1111/obr.13425. Epub 2022 Feb 9. Obes Rev. 2022. PMID: 35142020 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

433 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

433 results

Results by year